Chronic kidney disease-associated pruritus: what is known and its application in children.

Autor: Shah S; Texas Children's Hospital and Baylor College of Medicine, Houston, TX, USA. ssshah@texaschildrens.org., Onugha E; Texas Children's Hospital and Baylor College of Medicine, Houston, TX, USA., Swartz SJ; Texas Children's Hospital and Baylor College of Medicine, Houston, TX, USA.
Jazyk: angličtina
Zdroj: Pediatric nephrology (Berlin, Germany) [Pediatr Nephrol] 2024 Jan; Vol. 39 (1), pp. 25-35. Date of Electronic Publication: 2023 May 12.
DOI: 10.1007/s00467-023-05998-8
Abstrakt: Chronic kidney disease-associated pruritus (CKD-aP) or uremic pruritus (UP) is a frequent symptom in patients with kidney failure receiving kidney replacement therapy. Severe chronic kidney disease-associated pruritus correlates with poor outcome in patients on dialysis. It is multifactorial in etiology and has a significant impact on quality of life. There is, however, limited data for children. This review summarizes current epidemiology, clinical characteristics, pruritus scoring systems, and available therapeutic options for pruritus in patients with chronic kidney disease and those receiving dialysis. Optimal care requires proper awareness of the severity of symptoms, the impact on quality of life, and the possible long-term outcomes. Optimizing dialysis prescription and correcting electrolyte abnormalities are important treatment targets. A wide range of therapeutic options is also available although none are well-studied in children. An earlier recognition of this debilitating symptom in children and treatment is imperative. A higher resolution version of the Graphical abstract is available as Supplementary information.
(© 2023. The Author(s), under exclusive licence to International Pediatric Nephrology Association.)
Databáze: MEDLINE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje